Evaluating Ebola vaccine trials: Insights from simulation

The Lancet Infectious Diseases

Volumn 15, Issue 10, 2015, Pages 1134-

  Pulliam, Juliet R C ^a   Bellan, Steve E ^b   Gambhir, Manoj ^c,d   Meyers, Lauren Ancel ^b,e   Dushoff, Jonathan ^f  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c MONASH UNIVERSITY   (Australia)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e SANTA FE INSTITUTE   (United States)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

DRUG SCREENING; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; HUMAN; INCIDENCE; INFECTION RISK; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIERRA LEONE; SIMULATION; STUDY DESIGN; VACCINATION; VALIDITY; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; ISOLATION AND PURIFICATION;

DISEASE OUTBREAKS; EBOLA VACCINES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84942100514     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00303-5     Document Type: Letter

References (5)

1. Piszczek J, Parlow E Stepped-wedge trial design to evaluate Ebola treatments. Lancet Infect Dis 2015, 15:762-763.
2. Sierra Leone to introduce a vaccine against Ebola (STRIVE) Centers for Disease Control and Prevention, (accessed July 2, 2015). http://www.cdc.gov/vhf/ebola/strive/qa.html.
3. Bellan SE, Pulliam JRC, Pearson CAB, et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis 2015, 15:703-710.
4. Tully C, Lambe T, Gilbert S, et al. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. Lancet Infect Dis 2015, 15:356-359.
5. Hussey M, Hughes JP Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007, 28:182-191.